A Popular Bakery From China Brings Wagyu Croissants to Its First U.S. Location in Beverly Hills
Rendering of Hi Bake in Beverly Hills Hi Bake
A new destination for custard tarts and red bean croissants is opening in the heart of Beverly Hills. Hi Bake, an Asian bakery founded in Hong Kong but now based in Chengdu, is opening its first U.S. location in Beverly Hills on July 17. Founded in 2012, Hi Bake has expanded to 60 stores across China. The bakery will open in partnership with Chubby Group, which operates restaurants including Niku X, Chubby Cattle, and Chubby Curry.
Hi Bake's signature lineup of French and Asian-inspired sweets include delicate, buttery croissants stuffed with molten chocolate lava or wagyu beef. Tarts go beyond the classic custard with flavors like strawberry, pistachio, and chocolate. Sweet and savory toasts will come topped with red bean, meat floss, pork jerky, and coconut.
Hi Bake is the latest arrival in a year that witnessed multiple Asia-based bakeries expand to the U.S. Popular South Korean dessert cafe, Cafe Knotted, opened at Westfield Century City in April, and Japan's Bread, Espresso & landed in Redondo Beach in January.
Hi Bake will be located at 235 N. Canon Drive, Beverly Hills, CA 90210.
Pre-order tacos and burritos from El Ruso
Famed taco truck El Ruso may be temporarily closed, but this weekend there's still a chance to enjoy owner Walter Soto's cooking. Soto is taking pre-orders for tacos and burritos for pickup on Sunday, July 13, in Silver Lake. Orders can be placed by calling or texting 213-502-1272, but supplies are limited.
A new executive chef at Majordomo
James Bailey, the new chef of Majordomo in Los Angeles. Majordomo
There's a new executive chef at Chinatown restaurant Majordomo. James Bailey, who was most recently the executive chef of Momofuku Las Vegas, has stepped into the role. Beyond Momofuku, Bailey's resume includes Bouchon Las Vegas, Carbone Las Vegas, and Noma.
Chez Jay's anniversary party
Santa Monica restaurant Chez Jay is celebrating its 66th Anniversary on August 9 with a full day of events. Look forward to live music, a classic car display, and a three-course prix fixe dinner in the main dining room. Book tickets on Resy.
Summer specials at Ggiata
As summer heats up, Ggiata has dropped its latest lineup of specials. Starting Friday, July 11, the Italian sandwich shop will serve a Chinese chicken salad wrap, a California club sandwich, and a classic Chinese chicken salad at all of its locations.
Eater LA
All your essential food and restaurant intel delivered to you Email (required)
Sign Up
By submitting your email, you agree to our Terms and Privacy Notice . This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fox News
22 minutes ago
- Fox News
Humanoid robot swaps its own battery to work 24/7
Robots used to need our help to keep going. They had to be plugged in or manually recharged. Now, UBTech is changing that. The company's new humanoid, the Walker S2, has a feature that could reshape the future of factory work. It can swap out its own battery, requiring no human intervention. That means it can keep going, almost nonstop, 24/7. Sign up for my FREE CyberGuy ReportGet my best tech tips, urgent security alerts and exclusive deals delivered straight to your inbox. Plus, you'll get instant access to my Ultimate Scam Survival Guide — free when you join my Instead of shutting down to recharge, the Walker S2 walks to a nearby swap station. When one battery starts to run low, the robot turns its torso, uses built-in tools on its arms and removes the drained battery. It then picks up a fresh one, plugs it in and gets back to work immediately. The entire process takes about three minutes. This system is similar to battery-swapping tech used in electric vehicles. But this time, it's for humanoid robots. The Walker S2 is the size of a small adult. It's 5 feet, 3 inches tall and weighs 95 pounds. It has two 48-volt lithium batteries. When one runs out, it switches to the other. Each battery lasts approximately two hours while walking or four hours when the robot is standing still. Swap stations also monitor battery health. If a battery starts to degrade, a technician can replace it. UBTech claims the Walker S2 is designed for real-world use. It has been tested in car factories operated by BYD, Nio and Zeekr. These robots are not just for show. They have vision systems to detect battery levels. A green light indicates that a battery is ready to use. The robot reads that, picks it up and plugs it in using a USB-style connector. The robot also features a display face to communicate its status to human workers. And, yes, there's an emergency stop button, just in case. China is investing heavily in robotics. More than 1,600 robotics companies operate in Shenzhen, UBTech's home base. Projects range from humanoids like the Walker S2 to delivery robots that ride the subway and restock convenience stores. This move toward automation is about global competition. China is betting on AI and robotics to lead the next era of manufacturing. Robots like the Walker S2 are built to work nonstop. That changes what the workplace looks like, not just in factories, but everywhere. You could start seeing machines like this in airports, warehouses or even hospitals. They handle the physical tasks. You focus on the thinking, planning or managing. For businesses, 24/7 automation means more output without adding more staff. It keeps operations moving, day and night. This tech is no longer a preview of what's next. It's starting to show up on real job sites. UBTech's Walker S2 is an example of how automation is moving beyond the lab and into the workplace. With battery swapping, humanoid robots may soon be able to work longer hours than any human could ever do. They don't take coffee breaks. They don't sleep. They just keep going. Would you be comfortable working next to a robot that never needs rest, and would you worry it would eventually take your job? Let us know by writing us at Sign up for my FREE CyberGuy ReportGet my best tech tips, urgent security alerts and exclusive deals delivered straight to your inbox. Plus, you'll get instant access to my Ultimate Scam Survival Guide — free when you join my Copyright 2025 All rights reserved.
Business Insider
an hour ago
- Business Insider
Upcoming Stock Splits This Week (July 28 to August 1)
These are the upcoming stock splits for the week of July 28 to August 1, based on TipRanks' Stock Splits Calendar. A stock split is a corporate play that boosts the number of shares in circulation by handing out extras to existing shareholders, without changing the company's overall value. This reduces the price per share, making the stock more affordable and often more appealing to retail investors. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. But not all splits are about broadening appeal. Some companies flip the script with a reverse stock split, consolidating shares to boost the share price while shrinking the total share count. The company's market cap stays the same, but the higher price tag often helps meet listing standards like Nasdaq's minimum price rule, warding off the threat of delisting. Whether the goal is to court investors or stay in the game, these corporate maneuvers often send signals that smart traders are quick to pick up on. Let's take a look at the upcoming stock splits for the week. ChargePoint Holdings (CHPT) – ChargePoint is an electric vehicle (EV) charging infrastructure provider operating an extensive network of chargers and connected services. On July 9, ChargePoint announced a 1‑for‑20 reverse stock split scheduled to become effective on July 28. The split is intended to increase the per-share price and regain compliance with NYSE's minimum bid price requirement, after trading below the $1.00 threshold since January 2025. FOXO Technologies (FOXO) – Developing advanced payment-processing platforms for the dental and medical industries, FOXO is taking strategic action to stay compliant with NYSE American listing standards. On July 17, the board approved a 1‑for‑1.99 reverse stock split effective on July 27, with trading on a split‑adjusted basis starting July 28. Mersana Therapeutics (MRSN) – Mersana is a clinical-stage biotech developing antibody‑drug conjugates (ADCs) targeting cancer. On July 24, it announced a 1‑for‑25 reverse stock split, effective before market open on July 28. The split seeks to increase per‑share price to regain Nasdaq Global Select listing compliance after prolonged depressed stock price. Ikena Oncology (IKNA) – Ikena Oncology, am immuno‑oncology biotech company, received shareholder approval on July 15 for a 1-for-12 reverse stock split, to be implemented at the start of trading on July 28 – the same day it merges with Inmagene Biopharmaceuticals. Upon closing, the combined company will be rebranded as ImageneBio and begin trading on Nasdaq under the ticker symbol IMA. AgriFORCE Growing Systems (AGRI) – AgriFORCE Growing Systems, a Canada-based ag-tech and food systems company listed in the U.S., is going through a 1-for-9 reverse stock split. Shareholders gave the green light back on June 6, and the move will officially take effect when markets opened on July 28. The goal here is to get the share price back above Nasdaq's $1.00 minimum and stay in compliance with listing rules. Velo3D, Inc. (VLDX) – Velo3D, a leading innovator in metal 3D printing technology, is making a move to reposition itself in the market. On July 25, the company announced a 1-for-15 reverse stock split, set to take effect at the start of trading on July 28. To mark the change, Velo3D shares will temporarily trade under the ticker symbol VLDXD for 20 sessions before reverting back to VLDX. Senmiao Technology (AIHS) – Senmiao Technology, a U.S.-listed fintech and auto-finance company based in China, is streamlining its stock structure with a 1-for-10 reverse split. Announced on July 24, and set to take effect on July 29, the move aims to lift its share price to meet Nasdaq's listing standards. Silexion Therapeutics (SLXN) – Israel-based Silexion Therapeutics is a clinical-stage biotechnology company focused on developing personalized cancer vaccines and immuno-oncology therapies. On July 16, Silexion announced a 1-for-15 reverse stock split of its common shares, effective after market close on July 28, with trading on a split-adjusted basis beginning July 29. The reverse split is intended to boost the stock price and regain compliance with Nasdaq's minimum bid price requirement for continued listing. NaaS Technology (NAAS) – NaaS Technology is a China-based provider of EV charging services and software, listed on the Nasdaq. On July 14, the company announced a 1-for-4 reverse ADS split set to take effect on or about July 30. The move aims to lift the ADS price, ensure compliance with Nasdaq's minimum bid requirement, and strengthen its appeal to investors. Biodexa Pharmaceuticals (BDRX) – Biodexa Pharmaceuticals is a UK-based clinical-stage biotechnology company focused on developing treatments for diseases with unmet medical needs, including a Phase 3 trial for familial adenomatous polyposis and a Phase 2a trial for type 1 diabetes. On July 15, the company announced a 1-for-10 reverse ADR split, effective July 31. The goal is to raise the ADR trading price to meet Nasdaq's $1.00 minimum bid price requirement. Yoshiharu Global (YOSH) – Yoshiharu Global is a restaurant operator specializing in Japanese ramen and rolls, primarily located in Southern California and Nevada. On July 18, the board and shareholders approved a 4-for-1 forward stock split, record date July 28, with the additional shares distributed after market close on July 30, and trading on a post-split basis starting July 31. The aim is to increase stock liquidity and investor accessibility, making the shares more appealing to retail investors. TipRanks Stock Splits Calendar.
Yahoo
an hour ago
- Yahoo
JD.com, Inc.'s (NASDAQ:JD) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
It is hard to get excited after looking at (NASDAQ:JD) recent performance, when its stock has declined 2.2% over the past week. However, a closer look at its sound financials might cause you to think again. Given that fundamentals usually drive long-term market outcomes, the company is worth looking at. In this article, we decided to focus on ROE. Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. In short, ROE shows the profit each dollar generates with respect to its shareholder investments. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. How Is ROE Calculated? Return on equity can be calculated by using the formula: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for is: 16% = CN¥49b ÷ CN¥309b (Based on the trailing twelve months to March 2025). The 'return' is the profit over the last twelve months. So, this means that for every $1 of its shareholder's investments, the company generates a profit of $0.16. Check out our latest analysis for Why Is ROE Important For Earnings Growth? We have already established that ROE serves as an efficient profit-generating gauge for a company's future earnings. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Generally speaking, other things being equal, firms with a high return on equity and profit retention, have a higher growth rate than firms that don't share these attributes. Earnings Growth And 16% ROE At first glance, seems to have a decent ROE. Even when compared to the industry average of 16% the company's ROE looks quite decent. Consequently, this likely laid the ground for the decent growth of 8.6% seen over the past five years by Next, on comparing with the industry net income growth, we found that reported growth was lower than the industry growth of 12% over the last few years, which is not something we like to see. The basis for attaching value to a company is, to a great extent, tied to its earnings growth. What investors need to determine next is if the expected earnings growth, or the lack of it, is already built into the share price. By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. If you're wondering about valuation, check out this gauge of its price-to-earnings ratio, as compared to its industry. Is Making Efficient Use Of Its Profits? has a healthy combination of a moderate three-year median payout ratio of 31% (or a retention ratio of 69%) and a respectable amount of growth in earnings as we saw above, meaning that the company has been making efficient use of its profits. While has been growing its earnings, it only recently started to pay dividends which likely means that the company decided to impress new and existing shareholders with a dividend. Upon studying the latest analysts' consensus data, we found that the company's future payout ratio is expected to drop to 22% over the next three years. However, the company's ROE is not expected to change by much despite the lower expected payout ratio. Summary Overall, we are quite pleased with performance. Specifically, we like that the company is reinvesting a huge chunk of its profits at a high rate of return. This of course has caused the company to see a good amount of growth in its earnings. With that said, the latest industry analyst forecasts reveal that the company's earnings growth is expected to slow down. Are these analysts expectations based on the broad expectations for the industry, or on the company's fundamentals? Click here to be taken to our analyst's forecasts page for the company. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
